Microbot Medical Inc. MBOT
As ofNov 20, 2026, 3:49 PM EST
- YTD
- -66.10%
- 1 year
- -60.81%
5D +0.1488 (+28.01%)
- Market cap
- 45.54M
- EPS (ttm)
- -0.27
- Shares out
- 16.93M
- Forward P/E
- -1.87
- YTD return
- -66.10%
- 1-year return
- -60.81%
- 50-day average
- 0.9736
- Volume
- 1.36M
- Avg volume
- 900.60K
- Open
- 0.73
- Previous close
- 0.7433
- Day's range
- 0.6601 – 0.75
- 52-week range
- 0.52 – 2.86
- Beta
- 1.63
Key statistics
- 200-day average
- 1.00
- Enterprise value
- 9.37M
- Price / book
- 2.53
- Free cash flow
- -4.59M
- Total cash
- 6.46M
- Total debt
- 148.00K
- Return on equity
- -134.46%
- Short % of float
- 3.51%
Fundamental scorecard
5 of 25 checks passed on MBOT’s reported financials
5of 25 checks passed
- Value 1 of 5
- Growth 1 of 5
- Profitability 0 of 5
- Financial health 3 of 5
- Dividend 0 of 5
Statements to Sep 30, 2026.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 13, 2024 | Sep 1, 2024 | -0.17 | -0.20 | -0.03 | -17.65% |
| Aug 14, 2024 | Jun 1, 2024 | -0.17 | -0.17 | 0.00 | 0.00% |
| May 15, 2024 | Mar 1, 2024 | -0.17 | -0.17 | 0.00 | 0.00% |
| Mar 27, 2024 | Dec 1, 2023 | -0.25 | -0.26 | -0.01 | -4.00% |
| Nov 14, 2023 | Sep 1, 2023 | -0.25 | -0.21 | +0.04 | +16.00% |
| Aug 14, 2023 | Jun 1, 2023 | -0.31 | -0.25 | +0.06 | +19.35% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Jun 3, 2024 | HC Wainwright & Co. | reit | Buy | Buy |
| Apr 16, 2024 | HC Wainwright & Co. | main | Buy | Buy |
| Oct 18, 2023 | HC Wainwright & Co. | reit | Buy | Buy |
| Jun 26, 2023 | HC Wainwright & Co. | reit | Buy | Buy |
| Jun 6, 2023 | HC Wainwright & Co. | reit | — | Buy |
| May 9, 2023 | HC Wainwright & Co. | main | — | Buy |
About Microbot Medical Inc.
Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, and neurovascular spaces. It also provides NovaCross, an intellectual property and technology in the field of intraluminal revascularization devices with anchoring mechanism and integrated microcatheter. The company has a strategic collaboration agreement with Stryker Corporation for technology co-development; and Phase 2 collaboration agreement with Corewell Health for the development of LIBERTY endovascular robotic system. Microbot Medical Inc. was founded in 2010 and is based in Braintree, Massachusetts.
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Country
- United States
- Website
- microbotmedical.com
News
B. Riley Securities Maintains Buy on Microbot Medical, Lowers Price Target to $3
Citizens Maintains Market Outperform on Microbot Medical, Lowers Price Target to $2
12 Health Care Stocks Moving In Monday's Intraday Session
Crude Oil Down Over 2%; NY Manufacturing Activity Declines In November
Nasdaq Down Over 1%; Tyson Foods Earnings Top Views Microbot Medical Q3 EPS $(0.09) Misses $(0.08) Estimate, Sales $72.000K Miss $900.000K Estimate
Microbot Medical® Files 10-Q and Highlights Key Third Quarter Operating Achievements
12 Health Care Stocks Moving In Monday's Pre-Market Session
Why Take-Two Interactive Software Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
Microbot Medical Inc. (NASDAQ:MBOT) Stock Has Average Price Target of $5.08
Your note
Sign in to keep a note on MBOT — it syncs with the Stock Master app.
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Group Inc | 2.71% | 459,549 | 445.81K | Sep 29, 2024 |
| Blackrock Inc. | 0.81% | 137,375 | 133.27K | Sep 29, 2024 |
| Geode Capital Management, LLC | 0.78% | 132,217 | 128.26K | Sep 29, 2024 |
| AlphaCentric Advisors LLC | 0.59% | 100,000 | 97.01K | Sep 29, 2024 |
| UBS Group AG | 0.26% | 44,503 | 43.17K | Sep 29, 2024 |
| Hilltop Holdings Inc. | 0.18% | 30,689 | 29.77K | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 2.06% | 348,549 | 338.13K | Sep 29, 2024 |
| Vanguard Extended Market Index Fund | 0.64% | 108,034 | 104.80K | Sep 29, 2024 |
| Mutual Fund Ser Tr-AlphaCentric Robotics & Automation Fund | 0.59% | 100,000 | 97.01K | Sep 29, 2024 |
| Fidelity Extended Market Index Fund | 0.48% | 80,889 | 78.47K | Oct 30, 2024 |
| Fidelity Series Total Market Index Fund | 0.13% | 22,796 | 22.11K | Oct 30, 2024 |
| Fidelity Total Market Index Fund | 0.12% | 20,503 | 19.89K | Oct 30, 2024 |
